Active Biotech AB (ACTI) Stock Statistics & Valuation Metrics

Active Biotech AB has a market cap or net worth of kr270.64M. The enterprise value is kr245.54M.

Active Biotech AB has 1,230,164,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Active Biotech AB’s return on equity (ROE) is -1.23 and return on invested capital (ROIC) is -105.85%.

The current PE Ratio of Active Biotech AB is -1.16. Active Biotech AB’s PEG ratio is -0.29.

In the last 12 months, Active Biotech AB had revenue of 0.00 and earned -39.40M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -39.00M and capital expenditures 0.00, giving a free cash flow of -39.00M billion.

Active Biotech AB pays an annual dividend of ―, resulting in a dividend yield of ―

Active Biotech AB upcoming earnings date is Aug 21, 2025, TBA (Confirmed).

Active Biotech AB as a current ratio of 4.40, with Debt / Equity ratio of 5.07%

In the past 12 months, Active Biotech AB has paid 0.00 in taxes.

Active Biotech AB EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.53.

Active Biotech AB has kr26.20M in cash and marketable securities with kr1.10M in debt, giving a net cash position of -kr25.10M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Active Biotech AB is ―, which is 11.43% higher than the current price. The consensus rating is ―